We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promising Treatment for ALS and Spinocerebellar Ataxia Type 2

News   Apr 25, 2017 | Original Story from the NIH

 
Antisense Oligonucleotide Shows Promise in Treatment of ALS and Spinocerebellar Ataxia Type 2
 
 
 

RELATED ARTICLES

Assessment Changes Open Up Neuroscience Research to People With Intellectual Disabilities

News

Adaptations to the NIH cognitive function assessment could ensure that the battery can be used to assess the cognitive ability of people with intellectual disabilities, providing objective measures that could be used in a wide variety of studies.

READ MORE

What Makes a Monkey Drink Alone?

News

Researchers have uncovered a unique signature of neural synchrony that reflects either a pro-social or an anti-social decision being made.

READ MORE

Too Much of a Good Thing May Lead to Too Much of a Liver

News

A team of scientists suggest prolonged exposure to NRF2 and KEAP1 may contribute to enlargement of the liver and fatty liver diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE